Fanapt (Vanda Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Fanapt drug offered from Vanda Pharmaceuticals Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Vanda Pharmaceuticals Inc.
NON-PROPRIETARY NAME: iloperidone
SUBSTANCE NAME: ILOPERIDONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00


Fanapt HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFanapt from Vanda Pharmaceuticals Inc.
LABELER NAME: Vanda Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43068-101_acbaa136-7d9e-493d-95af-613f24bc58d9
PRODUCT NDC: 43068-101
APPLICATION NUMBER: NDA022192

Other ILOPERIDONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFANAPT
Mylan Pharmaceuticals Inc.Iloperidone
Novartis Pharmaceuticals CorporationFANAPT
Vanda Pharmaceuticals Inc.Fanapt